“Immune checkpoint inhibitors have transformed cancer treatment, but responses remain limited in some patients,” said lead author Dr. Simon Bernatz, of the AI in Medicine Program at Mass General Brigham, Boston, USA. He noted that current…
Study Shows Thymic Health is Linked to Cancer Patients’ Response to Immunotherapy
